Department of Ultrasonography, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Xinglong Lane, Changzhou, China.
J Ovarian Res. 2023 Aug 3;16(1):153. doi: 10.1186/s13048-023-01243-w.
Ovarian-Adnexal Reporting and Data System (O-RADS) for ultrasound is a lexicon and risk stratification system that includes all risk categories and relevant management recommendation. It has high sensitivity in diagnosing malignant adnexal tumors, but the specificity is lower.
To explore the value of O-RADS combined with contrast-enhanced ultrasound (CEUS) in risk stratification of adnexal masses.
A retrospective study was performed on 85 patients with 100 adnexal masses that preoperatively underwent conventional ultrasound as well as CEUS examination and obtained the postoperative pathological results. The masses were classified into O-RADS2, 3, 4, and 5 by conventional ultrasound. After contrast enhancement, the classification of O-RADS was adjusted according to CEUS imaging features. The O-RADS 2 and 3 lesions with suspected malignant features like irregular blood vessels or internal inhomogeneous hyperenhancement were upgraded to O-RADS 4, and the O-RADS 4 lesions with the above features were upgraded to O-RADS 5. The O-RADS 4 lesions with suspicious benign angiographic features like a regular vessel, interior hypoenhancement or non-enhancement were downgraded to O-RADS 3; the O-RADS 5 lesions with rim ring-enhancement and interior non-enhancement were downgraded to O-RADS 3. The sensitivity, specificity, accuracy, PPV, NPV, and AUC of the two methods were compared, taking pathological results as the gold standard.
The sensitivity, specificity, accuracy, PPV, NPV, and AUC of O-RADS and O-RADS combined with CEUS in the diagnosis of malignant adnexal tumors were 96.6%, 66.2%, 75.0%, 53.8%, 97.9%, 0.910 and 96.6%, 91.5%, 93.0%, 82.4%, 98.5%, 0.962, respectively. The specificity, accuracy, PPV, and AUC of O-RADS combined with CEUS were considerably higher than those of O-RADS (P < 0.01). Furthermore, both methods had excellent sensitivity and NPV but there were no significant differences between them(P > 0.05).
Combination of O-RADS and CEUS can significantly improve the specificity and PPV in diagnosing malignant adnexal tumors. It seems promising in the clinical application of risk stratification of adnexal masses.
卵巢-附件报告和数据系统(O-RADS)是一种超声词汇和风险分层系统,包括所有风险类别和相关的管理建议。它在诊断附件恶性肿瘤方面具有较高的灵敏度,但特异性较低。
探讨 O-RADS 联合对比增强超声(CEUS)在附件肿块风险分层中的价值。
对 85 例术前接受常规超声和 CEUS 检查并获得术后病理结果的 100 个附件肿块患者进行回顾性研究。常规超声将肿块分为 O-RADS 2、3、4 和 5 类。CEUS 增强后,根据 CEUS 成像特征调整 O-RADS 分类。O-RADS 2 和 3 类病变如不规则血管或内部不均匀强化等疑似恶性特征者升级为 O-RADS 4 类,O-RADS 4 类病变具有上述特征者升级为 O-RADS 5 类。O-RADS 4 类病变如规则血管、内部低增强或无增强等可疑良性血管造影特征者降级为 O-RADS 3 类;O-RADS 5 类病变如边缘环增强和内部无增强者降级为 O-RADS 3 类。以病理结果为金标准,比较两种方法的灵敏度、特异度、准确性、阳性预测值、阴性预测值和 AUC。
O-RADS 和 O-RADS 联合 CEUS 诊断恶性附件肿瘤的灵敏度、特异度、准确性、阳性预测值、阴性预测值和 AUC 分别为 96.6%、66.2%、75.0%、53.8%、97.9%和 0.910 和 96.6%、91.5%、93.0%、82.4%、98.5%和 0.962。O-RADS 联合 CEUS 的特异度、准确性、阳性预测值和 AUC 明显高于 O-RADS(P<0.01)。此外,两种方法的灵敏度和阴性预测值均较高,但差异无统计学意义(P>0.05)。
O-RADS 联合 CEUS 可显著提高诊断恶性附件肿瘤的特异度和阳性预测值,有望在附件肿块风险分层的临床应用中发挥作用。